Peripheral vascular disease

OBL Spotlight: Flint Hills Heart, Vascular and Vein Clinic

10/30/2020

Raymond Dattilo, MD, FACC, Manhattan, Kansas

Raymond Dattilo, MD, FACC, Manhattan,...

I believe the pendulum, which has swung to hospital employment for physicians, is swinging back, as physicians are becoming dissatisfied with hospital bureaucracy and the corporate business of patient care.

I believe the pendulum, which...

10/30/2020

Cath Lab Digest

Mississippi Delta Miracle: Angiographic Screening Yields Dramatic Reduction in Amputations

05/19/2020

Foluso A. Fakorede¹, MD, Bynthia M. Anose², PhD, Mary L. Yost³, MBA, Amy E. Harlow¹, RN, BSN, Brad J. Martinsen⁴, PhD

Foluso A. Fakorede1, MD, Bynthia M. A...

Prior to the affiliation of a peripheral interventional cardiologist within BMC, the institution performed zero peripheral angiograms and 56 major amputations. In just a few short years, CVSCM facilitated an 87.5% decrease in the...

Prior to the affiliation of a...

05/19/2020

Cath Lab Digest

Calcium Corner

Two-Year Results of IMPERIAL: First-Ever Randomized Study of Eluvia and Zilver PTX in Femoropopliteal Artery Lesions

01/01/2020

An interview with IMPERIAL trial co-principal investigator William A. Gray, MD, FACC, FSCAI, System Chief, Division of Cardiovascular Disease; President, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania.

An interview with IMPERIAL trial co-p...

The Eluvia stent utilizes a drug-polymer combination that provides a sustained release of paclitaxel over one year.

The Eluvia stent utilizes a...

01/01/2020

Cath Lab Digest

The Market Reacts Quickly: Changes in Paclitaxel Vascular Device Purchasing Within the Ascension Healthcare System

10/14/2019

Peter P. Monteleone, MD^1,2; Subhash Banerjee, MD³; Priya Kothapalli, MD^1,2; Ariel Dora Stern, PhD⁴; Daniel Fehder, PhD⁵; Ron Ginor, MD⁶; Dominic Vollmar¹; Edward T. A. Fry, MD^1,7; Mark J. Pirwitz, MD^1,2

Peter P. Monteleone, MD1,2; Subhash ...

A meta-analysis of trials in endovascular therapy suggested an increased mortality associated with treatment exposure to paclitaxel. We analyzed how this controversy impacted device purchasing and related utilization patterns in the period...

A meta-analysis of trials in...

10/14/2019

Journal of Invasive Cardiology

Case Report

Treatment of Critical Hand Ischemia via Orbital Atherectomy and Balloon Angioplasty in an African-American Hemodialysis Patient

09/05/2019

Abdul Bahro¹, MD, FACC, FSCAI, Connie Williams², AGACNP-BC, Zsuzsanna Igyarto³, PhD, Brad J. Martinsen⁴, PhD

Abdul Bahro1, MD, FACC, FSCAI, Connie...

In this report, we present the case of an African-American hemodialysis patient with CHI due to a calcified radial artery who was treated with orbital atherectomy and balloon angioplasty, and underwent follow-up at six weeks post procedure.

In this report, we present the...

09/05/2019

Cath Lab Digest

CLI Perspectives

4 French Access for Endovascular Procedures

07/29/2019

CLI Perspectives is headed by section editor J.A. Mustapha, MD, Advanced Cardiac & Vascular Centers for Amputation Prevention, Grand Rapids, Michigan.

J.A. Mustapha, MD, talks with William H. Julien, MD, South Florida Vascular Associates, Coconut Creek, Florida.

CLI Perspectives is headed by section...

All arterial punctures are performed with ultrasound guidance and 4 French (Fr) micropuncture.

All arterial punctures are...

07/29/2019

Cath Lab Digest

EP Tips & Techniques

Drug-Coated vs Uncoated Percutaneous Transluminal Angioplasty in Infrapopliteal Arteries: Six-Month Results of the Lutonix BTK Trial

07/23/2019

Jihad A. Mustapha, MD¹; Marianne Brodmann, MD²; Patrick J. Geraghty, MD³; Fadi Saab, MD¹; Richard A. Settlage, MS⁴; Michael R. Jaff, DO⁵; on behalf of the Lutonix BTK Study Investigators

Jihad A. Mustapha, MD1; Marianne Bro...

We hypothesized that a drug-coated balloon could improve treatment efficacy while maintaining safety when compared with percutaneous transluminal angioplasty for the treatment of atherosclerotic infrapopliteal arterial lesions.

We hypothesized that a...

07/23/2019

Journal of Invasive Cardiology

Case Files by Dr. George

Radial and Ulnar Artery Occlusion Following Transradial and Transulnar Coronary Intervention Requiring Endovascular Revascularization

06/07/2019

Mohammad N. Zabad, MD, Sean Janzer, MD, and Jon C. George, MD

Division of Cardiology, Interventional Cardiology and Endovascular Medicine,

Einstein Medical Center, Philadelphia, Pennsylvania

Mohammad N. Zabad, MD, Sean Janzer, M...

In the case presented herein, we discuss a patient who presented with right hand weakness and paresthesia following multiple previous coronary interventions using radial and ulnar arteries. She was found to have occlusion of both arteries,...

In the case presented herein, we...

06/07/2019

Cath Lab Digest

Case Series

Can Radial Access Be a Practical Alternative to Treat Peripheral Vascular Disease (PVD)?

05/01/2019

Richard R. Heuser, MD, FACC, FACP, FESC, MSCAI, Chief of Cardiology, St. Luke’s Medical Center; Professor of Medicine, University of Arizona School of Medicine; Phoenix Heart Center, Phoenix, Arizona

Richard R. Heuser, MD, FACC, FACP, FE...

We have been using the R2P Destination Slender (Terumo) and the attendant equipment in over 2 dozen cases during the last 6 to 8 months. We present three case examples to illustrate the promise of these sheaths, wires, and balloons, as well...

We have been using the R2P...

05/01/2019

Cath Lab Digest

Your Path to Success: Expert Advice

Physicians Are Pushing Boundaries With Transradial Access

05/01/2019

Gary Clifton, Vice President, Terumo Business Edge, talks with Richard Heuser, MD, and Gavin Lennan RT(R), Cath Lab Manager.

Gary Clifton, Vice President, Terumo ...

From a clinical standpoint, there are many benefits to going radial, including patient comfort, a reduced risk of complications, and a shorter recovery time, at 1.5-3 hours with radial compared to 4-12 hours (usually 6-8 hours, on average)...

From a clinical standpoint,...

05/01/2019

Cath Lab Digest